Ignite Creation Date:
2025-12-24 @ 6:45 PM
Ignite Modification Date:
2025-12-28 @ 11:24 AM
Study NCT ID:
NCT06190457
Status:
COMPLETED
Last Update Posted:
2024-01-05
First Post:
2023-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Intrathecal Rituximab in 16 Children of Stage Ⅲ、ⅣNon-Hodgkin Lymphoma
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2023-06-12
First Submit QC Date:
None
Study First Post Date:
2024-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-19
Last Update Post Date:
2024-01-05
Last Update Post Date Type:
ACTUAL